- Call for Abstracts
- Sponsorship & Exhibition
Shaji K. Kumar, MD, is Consultant in the Division of Hematology and Mark and Judy Mullins Professor of Hematological Malignancies at Mayo Clinic in Rochester, Minnesota. He is the Chair of the Myeloma, Amyloidosis and Dysproteinemia Disease Group at Mayo Clinic.
Dr. Kumar received his medical degree from the All India Institute of Medical Sciences in New Delhi, India. His postdoctoral training included a residency in Internal Medicine from the All India Institute of Medical Sciences, followed by an Internal Medicine residency and a hematology/oncology fellowship at the Mayo Graduate School of Medicine in Rochester, Minnesota.
Dr. Kumar’s research focuses on the development of novel drugs and drug combinations for the treatment of myeloma. He also focuses on the mechanisms of disease progression from precursor conditions of MGUS and smoldering multiple myeloma and risk stratification of plasma cell disorders. His laboratory focuses on understanding the role of bone marrow microenvironment in the development and progression of myeloma.
Dr. Kumar serves as Co-Chair of the NCI Myeloma Steering Committee and as Chair of the NCCN Multiple Myeloma Guidelines Panel. He also serves on the Board of the International Myeloma Society and International Society of Amyloidosis.